Sitagliptin phosphate monohydrate is an active pharmaceutical ingredient used in the manufacturing of medications for type 2 diabetes. It functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps regulate insulin and glucagon production.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 654671-77-9
Sitagliptin phosphate
pharmaceutical raw material
Sitagliptin monohydrochloride monohydrate
pharmaceutical raw material
Sitagliptin tartrate hemihydrate
pharmaceutical raw material
Sitagliptin hydrochloride
pharmaceutical raw material
Naftifine hydrochloride
pharmaceutical raw material
Inositol niacinate
pharmaceutical raw material
(S,S)-asenapine
pharmaceutical raw material
4'-demethylepipodophyllotoxin
pharmaceutical raw material
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid;hydrate
GQPYTJVDPQTBQC-KLQYNRQASA-N
C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N.O.OP(=O)(O)O